HawaiiSB 22212025–2026 Regular Session (Year 2)Senate

RELATING TO TERMINAL ILLNESSES.

Sponsored By: Stanley Chang (Democratic)

In Committee

Summary

Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions.

USDATerminal IllnessRight-to-TryInvestigative Drug or Biological ProductAccess to CareHHS, CPN/JDC

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Stanley Chang

    Democratic • Senate

Cosponsors

  • Kurt Fevella

    Republican • Senate

  • Joy A. San Buenaventura

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Referred to HHS, CPN/JDC.

    1/26/2026Senate
  2. Introduced and passed First Reading.

    1/21/2026Senate
  3. Pending Introduction.

    1/14/2026Senate

Bill Text

Related Bills

Back to State Legislation